Qiming Corporate GP VI, Ltd. sold $10.3M of ALMR (indirect holdings)
Qiming Corporate GP VI, Ltd. sold 342,626 indirectly-held shares of Alamar Biosciences, Inc. (ALMR) at an average of $29.92 ($29.00–$30.81, $10.25M total) across 24 trades over 2026-10-21 to 2026-10-22. Filed jointly with Qiming Managing Directors Fund VI, L.P. (10% owner), Qiming Venture Partners VI, L.P. (10% owner), Qiming GP VIII, LLC (10% owner), Qiming Venture Partners VIII Investments, LLC (10% owner), Qiming GP VIII-HC, LLC (10% owner) and Qiming Venture Partners VIII-HC, L.P. (10% owner).
How this was made
The 30-second read
Why it matters
The transaction reduces insider ownership and may be interpreted as a lack of confidence, potentially pressuring the stock.
Market read
Primary disclosure of a $10M insider sell; modest trading relevance.
What to watch
Potential upcoming financing needs or tax considerations for the insider.
Background
SEC Form 4 filing discloses an open‑market sale of ALMR shares by a major insider.
Ticker impact
Form 4 shows Qiming Corporate GP VI, Ltd. sold $10.3M of ALMR shares, reducing its stake to 1.79M shares.
likely pressure as the market prices in the insider sale
The sale represents a sizable $10M disposition by a major shareholder, which often precedes short‑term price weakness.
Market effects
Minimal; biotech sector may see slight caution but no broad impact.
U.S. market only; no regional ripple.
Low; isolated insider transaction.
Counterpoint
The sale could be a routine portfolio rebalancing, not a negative signal.
Key entities
- CompanyAlamar Biosciences, Inc.
Biotech firm whose shares were sold.
- InsiderQiming Corporate GP VI, Ltd.
10% owner executing the sale.
